Paying for cost-effective health care: Does it violate both static- and dynamic efficiency?
Recent research has questioned the rationales of using cost-effectiveness metrics of medical technologies to guide reimbursement. I discuss here the underlying ideas of this research, which argues that reimbursement based on cost effectiveness criteria leads to both static- and dynamic inefficiencie...
Main Author: | Tomas J Philipson |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Oslo
2015-03-01
|
Series: | Nordic Journal of Health Economics |
Subjects: | |
Online Access: | https://journals.uio.no/NJHE/article/view/1289 |
Similar Items
-
THE ACCESSIBILITY OF PHARMACEUTICALS REIMBURSED FROM THE COMPULSORY HEALTH INSURANCE FUND BUDGET IN TERMS OF PRICES IN 2009−2015
by: Gintarė Petronytė, et al.
Published: (2017-03-01) -
Cost-utility analysis: Current methodological issues and future perspectives
by: Mark J C Nuijten, et al.
Published: (2011-06-01) -
Budget impact of publicly reimbursed prescription medicines in The Republic of Srpska
by: Tamara ePetrusic, et al.
Published: (2015-09-01) -
Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market
by: Mihajlo B Jakovljevic
Published: (2014-03-01) -
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017-01-01)